--- title: "Shaanxi Micot Pharmaceutical Technology Co. (2335) stock" url: "https://aibio.space/companies/shaanxi-micot-pharmaceutical-technology/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Shaanxi Micot Pharmaceutical Technology Co., Ltd. (HKEX: 2335), China. The directory classifies it as Biotechnology." --- 2335 Shaanxi Micot Pharmaceutical Technology Co., Ltd. HKEX · China # Shaanxi Micot Pharmaceutical Technology Co. (2335) news Shaanxi Micot Pharmaceutical Technology Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2335, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Shaanxi Micot Pharmaceutical Technology Co. news We have not published a story on Shaanxi Micot Pharmaceutical Technology Co. yet. When there is news, it will appear here. ## Shaanxi Micot Pharmaceutical Technology Co. at a glance - **Ticker**: 2335 - **Listing**: HKEX - **Country**: China ### Related companies - [HJ Science Co.](https://aibio.space/companies/hj-science/) HKEX: 6132 - [Qingdao Vland Biotech INC.](https://aibio.space/companies/qingdao-vland-biotech/) SSE: 603739 - [Hubei Goto Biopharm Group Co.](https://aibio.space/companies/hubei-goto-biopharm/) SZSE: 300966 - [Beijing Tiantan Biological Products Corporation](https://aibio.space/companies/beijing-tiantan-biological-products/) SSE: 600161 - [Innovita Biological Technology Co.](https://aibio.space/companies/innovita-biological-technology/) SSE: 688253 - [Sunshine Lake Pharma Co.](https://aibio.space/companies/sunshine-lake-pharma/) HKEX: 6887 - [Frontier Biotechnologies](https://aibio.space/companies/frontier-biotechnologies/) SSE: 688221 - [Shanghai Obio Technology (Group) Corp.](https://aibio.space/companies/shanghai-obio-technology/) SSE: 688238 ### Also on HKEX - [Alphamab Oncology](https://aibio.space/companies/alphamab-oncology/) 9966 - [Zhaoke Ophthalmology](https://aibio.space/companies/zhaoke-ophthalmology/) 6622 - [Tianda Pharmaceuticals](https://aibio.space/companies/tianda-pharmaceuticals/) 455 - [Keymed Biosciences](https://aibio.space/companies/keymed-biosciences/) 2162 - [Sichuan Kelun-Biotech Biopharmaceutical Co.](https://aibio.space/companies/sichuan-kelun-biotech-biopharmaceutical/) 6990 - [Hanx Biopharmaceuticals (Wuhan) Co.](https://aibio.space/companies/hanx-biopharmaceuticals-wuhan/) 3378 ## Questions about Shaanxi Micot Pharmaceutical Technology Co. What is the ticker symbol of Shaanxi Micot Pharmaceutical Technology Co.? Shaanxi Micot Pharmaceutical Technology Co., Ltd. trades under the ticker 2335 on HKEX. Where is Shaanxi Micot Pharmaceutical Technology Co. listed? Shaanxi Micot Pharmaceutical Technology Co., Ltd. is listed on HKEX. Which country or territory is Shaanxi Micot Pharmaceutical Technology Co. listed under? Our directory records Shaanxi Micot Pharmaceutical Technology Co., Ltd. under China. What does Shaanxi Micot Pharmaceutical Technology Co. do? Our directory classifies Shaanxi Micot Pharmaceutical Technology Co., Ltd. as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of Shaanxi Micot Pharmaceutical Technology Co.? The ISIN recorded for Shaanxi Micot Pharmaceutical Technology Co., Ltd. is CNE100007Q79. Does aibio.space cover Shaanxi Micot Pharmaceutical Technology Co.? aibio.space lists Shaanxi Micot Pharmaceutical Technology Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to Shaanxi Micot Pharmaceutical Technology Co.? Companies in our directory listed in the same country and business area as Shaanxi Micot Pharmaceutical Technology Co.: HJ Science Co., Qingdao Vland Biotech INC., Hubei Goto Biopharm Group Co., Beijing Tiantan Biological Products Corporation, Innovita Biological Technology Co., Sunshine Lake Pharma Co.. ## Investor discussion: Shaanxi Micot Pharmaceutical Technology Co. Members talk about Shaanxi Micot Pharmaceutical Technology Co. (2335). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Shaanxi Micot Pharmaceutical Technology Co., newest first. Each line links the filing it comes from. 1. 2026-10-22 Financings Share or debt issue: PROPOSED GENERAL MANDATE TO REPURCHASE H SHARES AND NOTICE OF EXTRAORDINARY GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1022/2026102201592.pdf) 2. 2026-06-14 Financings Share or debt issue: GLOBAL OFFERING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0615/2026061500009.pdf) ## Press releases Headlines of Shaanxi Micot Pharmaceutical Technology Co.'s own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-10-22 HKEXnews [NOTICE OF EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1022/2026102201596.pdf) 2. 2026-10-22 HKEXnews [PROPOSED GENERAL MANDATE TO REPURCHASE H SHARES AND NOTICE OF EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1022/2026102201592.pdf) 3. 2026-10-15 HKEXnews [PROPOSED ADOPTION OF THE H SHARE INCENTIVE SCHEME AND PROPOSED GENERAL MANDATE TO REPURCHASE H SHARES](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1015/2026101501154.pdf) 4. 2026-09-30 HKEXnews [NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0930/2026093001927.pdf) 5. 2026-09-07 HKEXnews [VOLUNTARY ANNOUNCEMENT - INCLUSION IN THE STOCK LIST UNDER THE STOCK CONNECT PROGRAM (SHANGHAI-HONG KONG STOCK CONNECT AND SHENZHEN-HONG KONG STOCK CONNECT)](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0907/2026090701335.pdf) 6. 2026-08-28 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0828/2026082800311.pdf) 7. 2026-08-26 HKEXnews [VOLUNTARY ANNOUNCEMENT - COMPLETION OF PHASE II CLINICAL TRIAL OF MT200605 FOR ACUTE ISCHEMIC STROKE (AIS) IN CHINA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0826/2026082602041.pdf) 8. 2026-08-24 HKEXnews [VOLUNTARY ANNOUNCEMENT - INCLUSION OF THE COMPANY AS A CONSTITUENT STOCK OF HANG SENG COMPOSITE INDEX](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0824/2026082400327.pdf) 9. 2026-08-17 HKEXnews [VOLUNTARY ANNOUNCEMENT XTL6001 RESEARCH ACCEPTED FOR PRESENTATIONS AT EASD 2026 AND ASN KIDNEY WEEK 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0817/2026081701263.pdf) 10. 2026-08-10 HKEXnews [VOLUNTARY ANNOUNCEMENT PRECLINICAL AND PHASE I CLINICAL DATA OF MT200605 ACCEPTED FOR ORAL PRESENTATION AT THE 18TH WORLD STROKE CONGRESS 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0810/2026081001362.pdf) 11. 2026-08-03 HKEXnews [VOLUNTARY ANNOUNCEMENT PHASE II CLINICAL TRIAL OF MT200605 FOR ACUTE ISCHEMIC STROKE (AIS) REACHED PRIMARY ENDPOINT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0803/2026080304089.pdf) 12. 2026-07-24 HKEXnews [VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF MT200605 FOR ACUTE ISCHEMIC STROKE (AIS) COMPLETED DATABASE LOCK](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0724/2026072401306.pdf) 13. 2026-07-09 HKEXnews [VOLUNTARY ANNOUNCEMENT - FIRST PATIENT ENROLLED IN PHASE II CLINICAL TRIAL OF MT1002 FOR ANTICOAGULATION IN HEMODIALYSIS (HD) PATIENTS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0709/2026070900983.pdf) 14. 2026-07-03 HKEXnews [VOLUNTARY ANNOUNCEMENT - FIRST PATIENT ENROLLED IN THE PHASE IB/II CLINICAL TRIAL OF MT1002 FOR ACUTE ISCHEMIC STROKE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0703/2026070301971.pdf) 15. 2026-06-23 HKEXnews [ANNOUNCEMENT OF ALLOTMENT RESULTS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0623/2026062301227.pdf) 16. 2026-06-22 HKEXnews [TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0623/2026062300069.pdf) 17. 2026-06-22 HKEXnews [TERMS OF REFERENCE OF THE NOMINATION COMMITTEE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0623/2026062300067.pdf) 18. 2026-06-22 HKEXnews [TERMS OF REFERENCE OF THE AUDIT COMMITTEE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0623/2026062300063.pdf) 19. 2026-06-22 HKEXnews [Articles of Association](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0623/2026062300061.pdf) 20. 2026-06-14 HKEXnews [Documents on Display](https://www1.hkexnews.hk/listedco/listconews/sehk/dod/en.html) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:2335 on TradingView](https://www.tradingview.com/symbols/HKEX-2335/). ## Listing details Shaanxi Micot Pharmaceutical Technology Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2335, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Shaanxi Micot Pharmaceutical Technology Co., Ltd. - **Ticker**: 2335 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Biotechnology - **ISIN**: CNE100007Q79 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-2335/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/shaanxi-micot-pharmaceutical-technology/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Shaanxi Micot Pharmaceutical Technology Co. (2335) stock", 2026-10-31, https://aibio.space/companies/shaanxi-micot-pharmaceutical-technology/